Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 85619

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
April 14, 2020
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
MasterPharm LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

D-1269-2020
Recall number
D-1269-2020
Initiated
April 14, 2020
Classification
Class I
Status
Terminated
Recalling firm
MasterPharm LLC
Quantity
7260 capsules

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

Code information

Lot #02-27-2020:04@11, Exp. August 25, 2020.

Distribution pattern

Nationwide in the U.S.